Aquamephyton Related Published Studies
Well-designed clinical trials related to Aquamephyton (Phytonadione)
Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. [2003.11.10]
Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation. [2000.10]
Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. [1999.12.13]
Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation. [1993.10]
Well-designed clinical trials possibly related to Aquamephyton (Phytonadione)
Possible site-specific effect of an intervention combining nutrition and lifestyle counselling with consumption of fortified dairy products on bone mass: the Postmenopausal Health Study II. [2011.07]
Differential effects of vitamin K1 on AFP and DCP levels in patients with unresectable HCC and in HCC cell lines. [2011.06]
Nutritional supplementation of hop rho iso-alpha acids, berberine, vitamin D, and vitamin K produces a favorable bone biomarker profile supporting healthy bone metabolism in postmenopausal women with metabolic syndrome. [2011.05]
Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding study. [2011.04]
The cost effectiveness of a randomized controlled trial to establish the relative efficacy of vitamin K1 compared with alendronate. [2011.01]
Effect of oseltamivir treatment on anticoagulation: a cross-over study in warfarinized patients. [2010.12]
Effect of phylloquinone supplementation on glucose homeostasis in humans. [2010.12]
Accelerated resolution of laser-induced bruising with topical 20% arnica: a rater-blinded randomized controlled trial. [2010.09]
Hop rho iso-alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial. [2010.05]
Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations. [2010.05]
Accelerated resolution of laser-induced bruising with topical 20% arnica: a rater-blinded randomized controlled trial. [2010.04.20]
Can oral vitamin K before elective surgery substitute for preoperative heparin bridging in patients on vitamin K antagonists? [2010.03]
The role of topical vitamin K oxide gel in the resolution of postprocedural purpura. [2009.11]
The effect of different meals on the absorption of stable isotope-labelled phylloquinone. [2009.10]
Association of sequence variations in vitamin K epoxide reductase and gamma-glutamyl carboxylase genes with biochemical measures of vitamin K status. [2009.04]
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. [2009.03.03]
Effect of low dose vitamin K2 (MK-4) supplementation on bio-indices in postmenopausal Japanese women. [2009.02]
Vitamin K in hand osteoarthritis: results from a randomised clinical trial. [2008.11]
Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. [2008.10.14]
Six weeks phylloquinone supplementation produces undesirable effects on blood lipids with no changes in inflammatory and fibrinolytic markers in postmenopausal women. [2008.10]
Vitamin K supplementation does not significantly impact bone mineral density and biochemical markers of bone in pre- and perimenopausal women. [2008.09]
Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. [2008.09]
Vitamin K, circulating cytokines, and bone mineral density in older men and women. [2008.08]
Effect of vitamin K supplementation on bone loss in elderly men and women. [2008.04]
Topical amethocaine gel 4% for intramuscular injection in term neonates: A double-blind, placebo-controlled, randomized trial. [2008.01]
Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. [2008.01]
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation. [2007.11.27]
Effect of Consumption of Micronutrient Fortified Candies on the Iron and Vitamin A Status of Children Aged 3-6 years in Rural Haryana. [2007.11.07]
Vitamin K1 versus Vitamin K3 for Prevention of Subclinical Vitamin Deficiency: A Randomized Controlled Trial. [2007.11.07]
Vitamin K1 versus vitamin K3 for prevention of subclinical vitamin deficiency: a randomized controlled trial. [2007.11]
Effect of vitamin A and zinc supplementation on gastrointestinal parasitic infections among Mexican children. [2007.10]
Daily vitamin K supplementation improves anticoagulant stability. [2007.10]
Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. [2007.09.25]
Idraparinux versus standard therapy for venous thromboembolic disease. [2007.09.13]
Comparative studies on effect of risedronate and alfacalcidol against glucocorticoid-induced osteoporosis in rheumatoid arthritic patients. [2007.09]
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study. [2007.07.10]
Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. [2007.07]
low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP). [2007.07]
Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K. [2007.07]
Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South african children: a randomized controlled trial. [2007.06.27]
Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. [2007.04]
Diuretic, hypotensive, and hypocholesterolemic effects of Eclipta alba in mild hypertensive subjects: a pilot study. [2007.03]
Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women. [2007.02]
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harms. [2007.01]
Zoledronic Acid in Reducing Clinical Fracture and Mortality after Hip Fracture. [2007]
Effect of calcium, vitamins K(1) and D(3) on bone in galactosemia. [2006.11]
Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women. [2006.11]
Prenatal vitamin K1 administration in epileptic women to prevent neonatal hemorrhage: is it effective? [2006.06]
Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants. [2006]
Dietary phylloquinone depletion and repletion in postmenopausal women: effects on bone and mineral metabolism. [2006]
Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. [2005.03]
Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. [2004.02]
Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. [2003.07]
Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding. [2003.03]
A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. [2002.11]
Menaquinone-4 in breast milk is derived from dietary phylloquinone. [2002.03]
Effects of a hydrogenated form of vitamin K on bone formation and resorption. [2001.12]
Reversal of excessive oral anticoagulation with a low oral dose of vitamin K1 compared with acenocoumarine discontinuation. A prospective, randomized, open study. [2001.01]
Phytomenadione or menadiol in the management of an elevated international normalized ratio (prothrombin time). [2000.12]
Vitamin K supplementation reduces serum concentrations of under-gamma-carboxylated osteocalcin in healthy young and elderly adults. [2000.12]
Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. [2000.08]
Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: comparison of younger and older adults. [1999.09]
Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation. [1999.01.15]
Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. [1998.09]
Interaction between vitamin K nutriture and bacterial overgrowth in hypochlorhydria induced by omeprazole. [1998.09]
Bioavailability of phylloquinone from an intravenous lipid emulsion. [1998.04]
Olestra's effect on vitamins D and E in humans can be offset by increasing dietary levels of these vitamins. [1997.08]
Effect of vitamin K1 supplementation on vitamin K status in cystic fibrosis patients. [1997.05]
Plasma concentrations of dihydro-vitamin K1 following dietary intake of a hydrogenated vitamin K1-rich vegetable oil. [1996.07]
Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulation. [1996.06]
Vitamin K1 concentration in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed-micellar preparation of phylloquinone. [1993.05]
Vitamin K in breast milk: no influence of maternal dietary intake. [1993.03]
Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants. [1992.10]
The effect of dietary vitamin K on warfarin-induced anticoagulation. [1991.06]
Placental transfer of vitamin K1 in preterm pregnancy. [1990.03]
Other research related to Aquamephyton (Phytonadione)
Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. [2006.02.27]
The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review. [2002.10]
Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy. [2001.03]
Phytonadione therapy in a multiple-drug overdose involving warfarin. [2000.10]
Solid dosage form preparations from oily medicines and their drug release. Effect Of degree of surface-modification of silica gel on the drug release from phytonadione-loaded silica gels. [2000.07.03]
Subcutaneous phytonadione for reversal of warfarin-induced elevation of the International Normalized Ratio. [1999.11.15]
Comparing different routes and doses of phytonadione for reversing excessive anticoagulation. [1998.10.26]
Symptomatic brodifacoum ingestion requiring high-dose phytonadione therapy. [1994.06]
Evaluation of bioavailability upon oral administration of phytonadione preparations in beagle dogs. [1993.03]
Pseudoscleroderma secondary to phytonadione (vitamin K1) injections. [1989.04]
Other possibly related research studies
[Level of vitamin K-dependent coagulation factors in premature infants and the influence of maternal antenatal administration of vitamin K(1) on their activity.] [2005.12]
Effects of vitamin K(1) on fluoride-induced bone changes in growing rats: a histomorphometric and radiodensitometric study. [2005.10]
Contact dermatitis due to clarifying cream. [2005.09]
Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer. [2005.07.20]
Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. [2005.08.01]
[Ingestion of a rodenticide with subsequent prolonged coagulopathy] [2005.07.15]
Determinants of plasma dihydrophylloquinone in men and women. [2005.05]
Viability and plasma vitamin K levels in the common bile duct-ligated rats. [2005.04]
Intake and sources of phylloquinone (vitamin K(1)) in 4-year-old British children: comparison between 1950 and the 1990s. [2005.04]
Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. [2005.05]
Vitamin K1 intake and coronary calcification. [2005.05]
Influence of plasma total antioxidant ability on lipid and protein oxidation products in plasma and erythrocyte ghost obtained from developing and adult rats pretreated with two vitamin K formulations. [2004.12]
|
